3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
31
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
5
Leukemia
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Sarcoma, Myeloid
2
Myelodysplastic Syndromes
2
Leukemia, Monocytic, Acute
2
Hematologic Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasms
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Basophilic, Acute
1
Down Syndrome
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Tretinoin
3
Arsenic Trioxide
3
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Gadolinium
1
Fluorodeoxyglucose F18
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
Daunorubicin
×
90 days
×
Clear all
No trials found.